

[ Mon, Aug 14th 2017
] - WOPRAI
[ Mon, Aug 14th 2017
] - WOPRAI
[ Mon, Aug 14th 2017
] - WOPRAI
[ Mon, Aug 14th 2017
] - WOPRAI
[ Mon, Aug 14th 2017
] - WOPRAI
[ Mon, Aug 14th 2017
] - WOPRAI
[ Mon, Aug 14th 2017
] - WOPRAI
[ Mon, Aug 14th 2017
] - WOPRAI
[ Mon, Aug 14th 2017
] - WOPRAI

[ Fri, Aug 11th 2017
] - WOPRAI
[ Fri, Aug 11th 2017
] - WOPRAI
[ Fri, Aug 11th 2017
] - WOPRAI
[ Fri, Aug 11th 2017
] - WOPRAI
[ Fri, Aug 11th 2017
] - WOPRAI
[ Fri, Aug 11th 2017
] - WOPRAI
[ Fri, Aug 11th 2017
] - WOPRAI
[ Fri, Aug 11th 2017
] - WOPRAI
[ Fri, Aug 11th 2017
] - WOPRAI
[ Fri, Aug 11th 2017
] - WOPRAI
[ Fri, Aug 11th 2017
] - WOPRAI
Christopher Marai Maintained (SNDX) at Strong Buy with Decreased Target to $22 on, Aug 11th, 2017
Christopher Marai of Nomura, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Decreased Target from $27 to $22 on, Aug 11th, 2017.
Christopher, nor any peers, have made any analyst calls on SNDX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30